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EF.2 = cpmrphnnc. 
ously have been demonstrated to result in physiologic ele- 
vations in the plasma cpinephrine concentration (6). To 
determine whether the etTects of epincphrine are influenced 
by the presence of heart disease, two groups of subjects 
were studied. one without and one with structural heart 
disease. 
The contribution of beta-adrenergic stimulation to the 
overall effects of epinephrine was dctcmdned in a third 
group of subjects in whom electrophysiologic variables were 
measured in the baseline state. after infusion of SO n&z per . _. 
min of epincphrinc and again after infusion of a heta- 
blwkmg dose of prop~anolol during continued infusion of 
cpinephrine. A fourth group of subjects first received Pro- 
praoolol. then epincphrbtc; in this group. any change from 
baselinc afler infusion of propmnolol was presumed to be 
caused by beta.adrenergic blockade. whcrcas any further 
change tier infusion of epinephrine was presumed to be 
caused by unopposed aloha-adrenergic stimulation. 
Subjects fudied (Table I), Each of the four study groups 
consisted OC 10 suhjacts. Subjects were selected from a pool 
ofpatients who ur,derwen: a clinically indicated electmphys- 
iologic study for evaluation of unexplained syocope, eon- 
sustained ventricular tachycardia or pllroxysmal supraven- 
tii~ular lachycardia. Patients were selected for inclusion in 
Group I only if they did not have evidence ofstructural heart 
disease based on clinical evaluation, echocardiography. ex- 
ercise treadmill testing or cardiac catheterization. Patients 
Were selected for inclusion in Group 2 only if they had 
undergone cardiac catheterization and had either coronary 
artery disease or a dilated cardiomyopathy. 
Patients were excluded from this studv if thcv had a 
history of myacardial infarction or cardiac iurgery kithi" 2
months before the electrophysiologic study or if they had 
inducible sustained ventricular tachycardia, uncontrolled 
hypcnension (systolic blood prcssurc >I70 mm Hg. dias- 
tolic blood presrorc >95 mm Hg). atrial fibrillation. unstable 
angina or severe congestive heart failure (New York Heart 
Association class IV). Patients were not selected to be 
subjecu in this study il they hd been treated with a 
beta-adrenergx blocking agent or with any drug that had 
alpha blocking propcnies (for example, labctalol. pramsin) 
within I week before the study. An addilional exclusion 
criterion for Groups 3 and 4 (patients who received intrave- 
nous propranololI was a left ven:cicular ejection frxtion 
c0.40. 
The clinical characteristics of the +I subjects in the four 
study groups arc listed in Table 2. The 24 subjects who did 
not have structural heart disease were not being treated with 
any medications at the time of the study. Among the other 
subjects. IO were being treated with a diuretic, 6 with 
digonin, 5 each with captopril or a calcium channel blocker, 
4 with isosorbide dinitrate sod 2 each with dipyridamole or 
aspirin. 
Ekrtrophysiologic sludy pmtoml. Electrophysiologic 
studies were performed with patients in the fasting, unscda- 
ted state after infomted consent had been obtained. Trcat- 
ment with all antiwrhythmic drops was discontinued at least 
four half-livea before the electmphysiologic study. The 
study protocol was approved by the Human Research Com- 
mittee at the University of Michigan Medical Center and was 
performed on completion of the clinically indicated portion 
of the elearophysiology lest. 
Three 6F quadripolar electrode catheters were inserted 
percutaneously into a femoral vein and positioned against 
the hi&. lateral right atrium, across the tricuspid valve far 
recording the His bundle electrogram and against he apx of 
the right ventricle. A short 5F cannula was inserted into a 
femoral artery for recording arterial prcssurc. Electrocardio. 
graphic leads Y,, I and 3. a high right atrial, aHis bundleand 
B right ventricular electrogram and the arterial pressure were 
displayed on an oscilloswpe and recorded on B Siemens- Epinephrine infusion. ARer measurement of baseline ar- 
Elcma Mingograf 1 recorder at a paper speed of IOil mm/s. terial prewre. sinus cycle length and electruphysiologic 
Pacing was performed with a programmable stimulator variable<. the subjects in Groups 1 and 2 received no infusion 
(Bloom Associates, Ltd.): the pacing stimuli had a pulse of 25 @kg per mitt of epinephrine. Previous studies have 
durstion of 2 ms and a current strength that was twice the demonstrated that during ir.fusion of epioephrine. steady 
diastolic threshold. ctate plasma cpinephrine concentrations are attained within 
Varisbln measurul. The following variables were mea- 10 mm 17.8). After 14 min. arterial Pressure, sinus cycle 
sured in the baseline state and after the administration of length and clcctrophysiologic variables wre remeasured. 
epinephrinc or propnnolol or both. depending on rbe <cud) The epinephrine infusion rate was then increased to 50 n&g 
*row: mean arterial pressure: spontaneous sinus cycle per min. and after en additional I4 min the arterial pressure, 
length: atrioventricular (AV) node conduction time (AH sinus cycle length and electrophysiolagic variables were 
interval) and infrattodal conduction time (HV interval) dor- meawed again. 
ing atrial pacing at cycle lengths of 6Oil and 500 ms: the The wb~ect~ in Groups 3 and 4 received epinepbrine at 
maximal corrected %ms node recovery time. determined by only one mfocxon rate. SO nglkp per min. either before or 
atria, pacing at cycle !engtbs of 6rJJ; 5?H?. 4: 350 and 300 after an infusion of propranoloi. None of the subjects expe- 
ms: the longest atrial pacing cycle length resulting in AV rienced an adverse reaction to the infusion of epinephrine. 
node Wenckebach block, determined in decrements of 10 Propranolol itdttsimt. Pmpranolol was administered in a 
tns: the antemgmde effective and functional refractory peri- dose of 0. IS mgikg at a rate of I mglmin. This dose has been 
ads of the AV node and the elective refractory period of the demonstrated previously to block the effects of beta- 
right atrium, determined by scanning diastole with a single adrenergic zt~molation on sinus cycle length in humans (9). 
atrial extrastimulus in 10 ms steps during a basic drive cycle The mean dose of propranolol was Il.7 + 2.7 mg (*SD) in 
length of 500 ms: the width of the QRS complex during Group 3 and 12.5 f 2.6 mg in Group 4. Elec!mphysiologic 
ventricular pacing at a cycle length of &?it and 300 ms. used 
variables were measured 5 mm after infusion of the loading 
dose. 
as an index of global intraventricular conduction, and the 
ventricular effective refractory period, determined by scan- 
The plusmn proprmolol comentmrion was measured by 
ning diastole with a single ventricularextrastimulur and with 
high performance liquid chromatography with fluorescence 
eight beat drive trains at cycle lengths of 6GQ. 500 and 4W 
detection from blwd samples drew from the femoral artery 
ms. The intertrain interval during refractory period determt- 
(101. With the assay used, the range of plasma propranolol 
nations was 4 s. 
concentrations associated with beta-blockade is SO to 100 
In 8 of r/z 40 wbjcas, determination of the AV node 
@ml. In Group 3, the mcaa plasma propranolot cmxentm- 
lion on completiwt of testing after infusion of propnnolol 
eUective refractory period was limited by the attial effective was 68 - 8 nglml. 
refractory period In 6 of 20 subjects who received propran- 
dol, determination of the AV node effective and fmtctianal 
ba Croap 4. the loading dose of propranolol was followed 
by a continuous infusion of 0.1 mglmin, which previously 
refractory periods at a basic drive cycle lcngtb of SW ms was had been chow to maintain a constant plasma proprmolol 
not possible because of AV Wenckebach block during bait 
drive. In 6 of the 40 subjects, the sinus cycle length during 
concemretion (I I). A&r the effects of propranolol were 
determmed, 50 @kg per min of epinephrine was infused 
infusion of 25 or 50 ngfkg per min of epinephrine was <600 during continued infusion of propranolol at a rate of 0.1 
ms, preventing the determittalion of the ventricular effective mgimin. The mean plasma propranolol cowent;alion on 
refractory period at a basic drive cycle length of 600 ms. 
In Gmrps I and 2, programmed ventricular stimulation 
completion of testing after infusion of proprattolol wee 77 2 
16 nglml, decreasing to 70 i I5 nglml on completion of 
was performed with single. double and triple ventricular testing after infusion of epinephrine plus proprarmlsl. 
extrdstimuli at a basic drive cycle length of MXI. SO0 and 4Oil Determination d ~b+snm e*tecimtmnine ccmealrathws. 
ms. Programmed stimulation was performed in the baseline Anrnal samples for catecbolamine determinations were 
state and after the administration of epinephrine to deter- drawn from the femoral artery with the indwelling c~nnula. 
mine whether epinephrine facilitates the induction of ventri- Two bare:ine samples were drawn I to 2 min apart. aftera IO 
culat lachycardia. In accord with the criteria for selection of to I5 min rest period. Samples were also drawn on comple- 
subjects none of the patients in Group I or 2 had inducible lion or testing at each infusion rate of epinephrine in Groups 
susmined ventricular tachycardia in Ihe baseline state. Sua- I and 2 and on completion of testing after infusion of 
tained ventricular tachycardia was defined as ventricular epinephrine and propmnolol in Groups 3 and 4. Plasma 
tachycardia z-30 s in duratmn or requiring direct correot epinephrine and norepinephrine concentrations were otca- 
countershock to lerminate. Nonsustained vetdrictdar tachy- wed by a single isotope radioenzymatic assay (12). Among 
ca:dia was defined as ventricular tachycardia that was six the 160 determinations of the plasma epinephritte and nor- 
bears to M s in duration. epinephrmc coocentrations during a drug infusion. 6 were 
excluded because grossly elcvatcd plasma concentrations 
seggeated contamination of the plasma samples by infusate. 
Statical emdysis. Variables were analyzed statistically 
with a repealrd meawes analysis of variance to determine 
the effects of eoineohrine or orooranolul. the effects of heati 
disease and i~ter&wns be&e& epinephrine effects and 
hean disease effects (13;. When data were mtssing.. a bal- 
anced repeated measures analysis of cowiance with use of 
the covariates to adjust for tbe missmg observations war 
performed (14). Multiplfi~ comparisons wre performed using 
tishcr’s least significant ditTerence procedure (13). 
For the variablrs that were affected by eoineuhrine, the 
presence of P liaear or nonlinear (quadratic) ho& etrect was 
tested within the framework of $5 repeated measures anal- 
ysis of variance with orthogonal polynominals (13). A p 
value to.05 was considered significant. Variables are ex- 
pressed as mean + I SD. 
RMlltS 
Effects d epiaephrbw in subjects with and without beart 
d&ax (Gmups I md 2) (Tabk 3). There were no signilicont 
diLrences in the effects of epinephrine between these two 
groups of subjects and therefore data in the two groups were 
pouted. The 2S and 50 @kg per min infusions of epinephrine 
were equivalent o actual doses of :.9 ? 0.3 an63.8.t 0.5 
&min, respectively. The two infusion rates of epinephrine 
resulted in a rwxessive increase in the plasma ednepbrine _ 
ar,d norepinephrine concentrations. 
Epinephrine had no e&t on mean arterial pressure, 
corrected sinus node recovery time, HV inter& or QRS 
ing electmphysioiogic variables during administration of the 
effects were Ii&r for all of these variables except sinus 
duration at a ventricular pacing cycle length of f&l0 or 300 
ms. There was a omgressive decrease in each of the remain. 
25 and 50 &kg per min infusions of epinephtine. The dose 
cyck length and AV node functional refractory period, 
which were affected in a nonlinear fashion. 
Effects 01 epincphrine on the induction of verttrienlar 
tachynrdia ~GWUDS I and 2~ The IO subiects in Grow I. 
branch block configuration. an inferior axis and a cycle 
length of 230 ms was induced in one of these patients by 
double extrastimuli. Sustained ventricular tachycardia that 
had a right bundle branch block configuration. infermr a& 
and cycle length of 270 ms was induced by double extrasti- 
muli in the other patient during the 50 &kg per min infusion 
ofepinephrine. The other eight subjects with structural heart 
d&se bad no inducible ventricular tachycardia in the 
baseline state or during infusion of epinephtine. 
EUeets of ealneohrine. 50 nelknlmia. folhwed bv txo~ran. 
dd during c&i&d infkion if eiiaephrine (Gmu~ j) &hk 
4). The mean cpincphrine dose was 3.9 f 0.9 p&in. The 
plasma epinephhne &centration increased uring infusion 
of epinephrine then increased significantly after administra- 
tion of propmnolol despite no change in the epinephrine 
infusion rate. 
Tbe mean arterial pressure decreased from 95 f 8 to 90 f 
IO torr daring infusion of epinephrine (p < 0.05). After the 
infusion of pmpranolol, the mean arterial pressure increased 
to a level of 104 + 7 torr. which was significantly higher than 
baseline (p < 0.001). 
The spontaneous cycle length shortened after infusion of 
epinephrine then increased to a wlue greater than baseline 
after infusion of propranolol. Neither epinephrine nor pro- 
pranolol had any significant effects on the corrected sinus 
node recovery time, HV interval or QRS width during 
ventricular pacing at a cycle length of 600 or 300 ms. The 
remaining variables each shortened significantly after the 
infusion of epinephrine: propranolol resulted in a lengthen- 
ing of these variables to values that were significantly greeter 
than baseline. 
EBcrk cd pmpranotd followed by epimphrine during 
eontbme4 iafurien d ~latnmnok4 (Gram 41 (Table 5). The 
mean epinephrine do& & 4.1 2 0.9 &dn. The plasma 
of pr~pranolol, then again increased after the infusion of 
cpinephtine concentration increased after the administration 
epinephrine. Propranolol had no e&cl on the meat! arterial 
pressure. After the infusion ofepinephrine, the mean arterial 
pressure increased 1 I2 -t I2 mrr, which was significantly 
higher than baseline CD < 0.001). 
who did not hav; stnxtur~l heart diseaie, did not &e 
inducible ventricular lachycardis in the baseline state. Dur- 
ing infusion of epinephrine at rates ui 25 and 50 @kg per 
min. sustained polymorphic ventricular tachycardis at a 
cycle length of 200 ms was induced by triple extrastimub m 
one patient. Ventriculsr tachycardia remained noninducible 
in the other nine paticms. 
-The spontaneous c&e length was increased by propran- 
ok& then relcained unchanged after the addition of epineph- 
rine. Tbe indexes 6fl.V node function (AH interval. longest 
atrial pacing cycle length resulting in AV node Wenckebach 
conduction, AV node effective and functional refractory 
periods) were all lengthened by proprartolol, then remained 
unchanged after the infusion of epinephrine. 
The mm orrio/ and venlricuhr effective refractory peri- 
ods increased after the adminiamtion of !xootanolol. then 
ventncular tachy&dia had inducible non&stained polymer- again increased significantly atier the i&s& of epineph- 
phic ventricular tachycardia t a cycle length of 220 to 230 tine. The individual responses to the infusion of epinephrine 
mr uiin double extrastbnuli in the baseline state. During the in the setting of beta-blockade consisted of the following: I) 
infusion of 25 nglkg per min of epinephrine. sustained atrial effective refractory period-an increase of IO to 40 ms 
unimorphic ventricular tachycardia that had a right bundle in six subjects and no change in four subjects: 2) ventricclar 
Atrial ERP,ms, 
AH lms11 
AV “tit Wrnckebach block ,mr,: 
HV (mrlt 
VERP DCL 6w mr 
VERP DCL 513 rns 
YERP DCL 03 ms 
QRS complcr DCL 6w mr 
r 
I+? 
I 
It! 
I 
I*? 
effc‘c:lwe r fracuxy period at a basic drive cycle length of600 
ms-an increw of IO to 20 ms in six subjects and no change 
in four rub,cctr: 3) ventricular effective refractory period at 
u basic drive cyctc length of500 mr--an increase of 10 ms in 
six subjects and no change in four subject,: and 4) ventricu- 
lar effective rcfraclory period at a basic drive cycie tenglh of 
4CM rns-an increase al IO to 20 ms in four subjects and no 
change in SIX subjects. 
Discussion 
Overall etectrophysiatogic etfecte of epinephrine. The 
doses of epinephrine tested in Groups I and 2 resulted in 
plasma cpine~hrine concentralions comparable with the 
plasma concentralions that occur during a variety of physi- 
ologic and pathophysiologic stales in humans. The k!asma 
epinephrine concernradons produced by the 25 nglkg per 
ndn infusion of epinephrine were in the range of plasma 
concentraalionr observed during cigarette smoking (IS), pub- 
tic speaking (16). submaximal exercise (6). mild hypogtyce- 
mia IIS). dentd exlraaion (17) and surgery (18). The 50 
ndks per min infusion of epinephrine resuhed in plasma 
concentrarionr in the range observed during maximal exer- 
cise 161. acute myocardiat infarction 09, 2Ot, diabetic keLo- 
acidosis (151 and sc~crc hypoglycemia 115). 
shortening of refractoriness in the atrium, AV node and 
venlricle and in improvement in AV node conduction. as 
reflected bv shorlcnine of the AH interval sod the loneest 
alrisl p&g cycle length associated with AV node W&k- 
ebach block. However. neither dose of epinephtine had any 
measurable effect on the sinus node recavery time, His- 
Purkinje conduction (the HV interval) or global inlravenni- 
cular conduction (the QRS width during ventricular pacing). 
Therefore, the overall electmphysiotogic response to epi- 
nephrine in rhe human hean consists of a generalized short- 
ening of refractorincrs in the atrium, AV node and venwicte. 
an improvement in AV node conduction and no change in 
His-Purkinje or intruvrntricutar conduction. 
?hese elecrrophysiulogic ejJccrs of epinephrine are con- 
sisrrnr wirk rhc followinn known ceJlufor effects of beru- 
odrenrr@c rrimalarion: shortening of the action potential 
duraion in atriat and venlricutar myocardium and in the AV 
node, an increase in upstroke velocity of the action potential 
in the AV node and no eiTect on the upstroke ~~!“ri:y of the 
action potentttt in the HinPurkinje system or ventricular 
myocardium (2). 
Alpha- and befa.adrenrrgic eff&s uf op,nephrtne. The 
administration of ~ro~ranolot after eoineohrine demon- 
sln:cd that beta-dre&dc blockade &kcr all of the 
electmphysiologic effcc~s of epinephrine. Therefore, the 
(1yeratl electropilysiologic effects of epinephrine result from 
stimutarion of beta-adrenergic receptors. However. beta- 
adrenergic blcckade noi only rcvened the etectrophysiata- 
gic effects of epinephrine, bul also resulted in a significant 
lengthening of refractory periods and slowin; of A’/ conduc- 
tion compared with basebne values. 
There ore rhrce oossihk erolonarion.~ For rhir ohrervo- 
rioa: I) Diet me~bmce e&s of prop;anolol may have 
resulted in prolongation of refraetoriners and slowing of AV 
node conduction compared with baseline. This possibility is 
unlikely because prior studies (11,21) have demonstrated 
that direct membrane effects al propra”olol OCEUT only at 
plasma concentrations >I50 nglml. whereas the plasma 
pmpranolot concentrations achieved in this study were 
always <IO0 “g/ml. 2; Propranolol may have eliminated the 
intluecce of tonic beta-adreneraic activitv on baseline refmc- 
toriness and AV node condu&an. Fo; example, beeawe 
beta-adrenergic tone at rest influences the sinus cycle length. 
the administmtion of propm”otot after epinephrine would 
have been expected to lengthen the sinus cycle length 
compared with baxline, as was observed. 3) Prolongation of 
refractory pwiods and slowins of AV node conduction 
compared with bawlirte may have resulted from rncppwed 
alpha-adrenergic stimulation by epinephrine in the presence 
of beta-adrenergic blockade. For example. the increase ill 
mean arterial prew~re compared with baseline values that 
occulred alter the administration of epinephrine plus pro- 
pranolol most likely was a result of stimulation of alpha- 
adrenernic rece~~tors. 
To disfirf&b rhe rjk?s vf be-w-odretwgic blockade 
from thv rffecis of alpha-udrcnryic srimalrnion, Group 4 
subjects received first propranolol then epinephrine. 
Chaws that occurred atier the administration of propnna- 
lol were presumed to result from blockade of :onic beta- 
adrenergtc acttvity, whereas any further changes that oc- 
curred after the infusion of epinepbrtne were presumed to 
result from alpha-adrenergic stimutatio”. 
presence of beta-adienergic blockade twitdpro~ranolol) had 
no e&cl on AV node refractory periods or conduction: 
however. it resulted in further ~mloncatafion of the effective 
refractory period in the atriumsnd &tricle. These results 
demonstrate that the electrophvsiolwic properties oftbe AV 
ttodc are not itdlttettced by alpha-adrenergic stimulation. 
whereas the atrial and ventricular effective refractors peri- 
ods may be pmlon:ed by alpha-adrensrgic atimuk&. 
Therefore, the electrophyriologic effects of circulating epi- 
nephtine on the AV node appears to be mediated solely by 
beta-adrenargic stimulation. fn contrast, the “et effect of 
;pinephrine on atrial and ventricular refractoriness is a 
shortening that is a result of predominant beta-adrenergic 
effects that are oartiallv offset bv an wuosinb aloha- 
adrenergx effect. 
Dim., YOrs”S indirect euects of ahlbh,ml~rRic stimlda. 
ti011. ?be prolo”gation of strial a& ventric& effective 
refrxtory periods during infusion of pmpranolol plus epi- 
nephrine in Group 4 may have been a direct effect of 
alpha-adrenergic stimulation. However. an indirect e&cl 
cannot be ruled out. The iwrease in mean arterial pressure 
that occurred during infusion of propranolol plus epineph. 
rine may have resuhcd in an increase in vagal input to the 
hean thrcueh the barorcccdcr reflex. A prior study (221 
demonstrated that vagal in& may prolong ventric&r re- 
fractoriness in humans by a direct action. Therefore. it is 
possible that the &as of alpha-adrenergic stimulation in 
Group 4 were mediated by an increase in vagal tone. 
However. because the sinus cycle length did not increase in 
association with the increase in mean arterial pressure, it is 
unlikely that the combination of pmpranolol plus epineph- 
rine resulted in a significant increase in vagal input to the 
heart compared with that induced by propranolol alone. 
effective refractory period’in hur&s is consistent with the 
resulls of prior expe~;mental studies. Al the cellular level, 
alpha-adrcnergic stimulation has been reported to prolong 
actmn potential duration in the guinea pig atrium (23). the 
rabbit papillary muscle (24) and the Purkinje fibers of sheep 
05). Govier et al. (26) reported that in the presence of 
Comparison with wstttts of prior studis. The demonstra- 
tion that alpha-adrenergic stimulation by epinephrine in the 
beta-adrewrgic blockade. noreoinephrine increases the 
cresence of beta-blockade ~ro,or,es the atrial and ventricular 
Rcllitntto~ of ventricular tarhycardia induction by opi- 
naphrine. Rior studies (30.30 bavc dcmonslrated that iso- 
cardia. The clinical signifi&ce of the sustained ventricular 
prctzrenol may facilitate the induction of ventricular tachy- 
cardia during programmed stimulaiion. In this study. 
tachycardia thal was induced during epinephrine infusion 
epinepht-ine also facilitated the induction of ventricular 
tachycardia in some parients. Epinephrine facilitated the 
therefore is unclear. However. facilitation of ventricular 
induction of sustained polymorphic ventricular tachycardia 
by triple extrastimuli in a subject without heart disease and 
tilehycardia induction by epinephrine during programmed 
also facilitated the induction of sustained unimorphic ventri- 
cular tachycardia in two subjects with co&my artery 
slimulation suggests that epinephrine may also facilitate the 
disease who had a history of nonsustained ventricular tachy- 
cardia. None of these three subjects had inducible sustained 
spontaneous induction of ventricular tachycatdia. 
ventriculartacbycardiabefore the administration of epineph- 
rine and none had a histow of sustained ventricular tachv- 
Plasma eoincobrine eancentratlons. The mean baseline 
functional refractory period in the i&ted rabbit atrium. plasma epinephine concentration and the mean eoncentra- 
Benfey and :‘?rma (27) demonstrated that norepinephrine lions during infusion of 25 and 50 ng/kg per min of epineph- 
and epineph ine prolong the effecriw refractory period in the rine in Groups I and 2 were three- to fivefold higher than the 
rabbit atrier.; by alpha-adrenergic stimulation in low concen- corresponding concentrations repone in a prior study (6) in 
traiion~ and shorten it by beta-adrenergic stimulation in which IO healthy subjects received the same doses of cpi- 
higher concentrations. nephrine used in the present study. This discrepancy is 
Few data are available on the effects 01 alpha-adrenergic attribumale to the use of arlerial plasma samples in the 
stimulation in the intact heart. Kowey et al. (28) reported present study and forearm vencus plasma samples in the 
thal alpha-adrene~gic stimulation with methoxamine or prior study. Forearm vencus epinephrine concentrations are 
phcaylephrine dots not affect ventricular refractoriness. 
Effect of heart disease. No ditferences in the effects of 
epinephrine were found between Groups 1 and 2. Therefore, 
hcwever, their study was performed in anesthetized ogs. 
the electrophysiolo8ic effects of epinephrine are qualila- 
lively and quantitatively similar in subjects with (Group 2) 
No studies before the present one hare examined the elw 
and without (Group I) heart disease. It has been demon- 
strated that transmural myocardial infarction in the canine 
trophysiologic effects of a!pha-adrenergic stimulation in the 
hean intemtpts sympathetic innervalion tc xminfarcted 
myocardium apical tc the infarction and that the drnervated 
human hean. 
rcgiuns show supersensitivr rhcnening of vcnlricular refrac- 
lory periods in response to sympathetic stimulation (29). Ln 
Ihe present study. although several patients had coronary 
#gamin infusion of epinephrine in six healthy subj&ti re- 
&Tectcd by local metabolism and h&e been demonstrated to 
sulted in a mean arterial plasma epinephrine concemwion of 
862 pElml (33). This is very similar to the mean artcriirl 
be considerably lower than arterial concentrations (32). The 
plasma concentration of 813 pglml achieved in Groups I and 
2 during the 25 n8lk8 per min infusion of epinepbrine, 
plasmaepinephrine concentrations achieved in our study are 
equivalent o a mean dose of 1.9 &min. 
consistent with the concentrations reported in other studies 
that also used arterial &ma samoles 1331. For examole. a 2 
Tlw odministruriou of propranolol in Group 3 resttlled in 
a significant incraw in the plasma epinephrine ccncentra- 
lion despite a constant epinephnne infusion rate. This cb- 
servation is consistent with the results of prior studies 1331 
that have demonstrated that eoineDhrine clearance is carll~ 
artery disease and a hiaxy of myocardial infarction, no& 
manifested supersenritive shortening of ventricular refrac- 
dependent on L beta-adrenerg& me~hanistn. Propran& hai 
tory periods in response to epinephrine. This finding was 
been shown to decrease substantially the clearance of epi- 
probably due to the site of determination of ventricular 
nephrine, thereby increasing the plasma epinephrine concec- 
tration (33). 
refractory periods; in Ihi study they were measured only at 
the cndocardium ofthe right ventricular apex. which was cot 
Pmhmgation of refractoriners by propranolol. In this 
representalive of the left ventricular myocardium apiczl to 
study, propranolol mildly prolonged the atrial and ventricu- 
infacted zones. 
lar effective refractory periods. resulting in a meon increase 
in these periods of6 to I3 rns. This observation suggests that 
beta-adrenergic stimulation may exett a tome ~ntluence in 
the atrium and ventricle, as is the case with the sinus and AV 
nodes. A prior study (34) in humam also found that proprao- 
olol may pmlong atrial refractoriness. Furthermore, a study 
(35) that utilized an open chest canine preparation reported 
that propranolol prolonged the ventricular effective rcfrac- 
tory period by a mean of 16 ms. However. other studies 
(22.36) in bumanr have reponed that proprdnotot does not 
significantly prolong ventricular refractoriness. These re- 
rult~ suggest hat the tonic sympathetic effect on ventriculnr 
refractotiness may not be present in all subjects. 
Limilatians. The eaineahrine mfusians used in this studv 
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